Taysha Gene Therapies reports on safety and efficacy results for the first patient to receive gene therapy for Rett Syndrome

Taysha Provides Update on Patient #1 and #2

November 14, 2023

Monica Coenraads
Chief Executive Officer
Rett Syndrome Research Trust

On November 14, 2023 Taysha Gene Therapies provided an encouraging update on Patient #1 and #2. Please see links below for clinical updates and timelines for US and UK trials.

Letter to Patient Advocacy Leaders

Taysha Press Release

Taysha Provides Update on Patient #1 and #2

Brought to you by

Connect with us